ArticleJournal of orthopaedics2025
Manual vs robotic patellofemoral arthroplasty outcomes: A Michigan arthroplasty registry collaborative quality initiative-based study.
Article in Journal of orthopaedics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 3 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed, 3 syntheses or guidelines pooled it.
- Robot-assisted total knee arthroplasty and the risk of postoperative infection: a systematic review and meta-analysis.Journal of robotic surgery · 2026Pooled it
- Patellofemoral vs. total knee arthroplasty for isolated patellofemoral osteoarthritis: evidence-based recommendations from a systematic review with GRADE assessment.Archives of orthopaedic and trauma surgery · 2026Pooled it
- Robotic-assisted patellofemoral arthroplasty shows superior functional outcomes and lower revision rates compared to conventional technique: a systematic review and meta-analysis.Archives of orthopaedic and trauma surgery · 2026Pooled it
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Historically, all patellofemoral arthroplasty (PFA) was performed manually. Recently, robotic-assisted PFA has gained popularity. The purpose of this study was to determine whether a robotic-assisted technique influenced outcomes and revision rates. We hypothesized that robotic-assisted PFA would have improved 90-day complication and revision rates. Methods: A single center's data from the Michigan Arthroplasty Registry Collaborative Quality Initiative (MARCQI) was queried for all primary PFAs from January 2014 to December 2022. Manual and robotic cohorts were compared for revisions and 90-day complications, including emergency visits, readmissions, and returns to the operating room (OR). Chi-square and Fisher's exact tests were used for categorical data and t-tests for continuous data. Results: Among 75 PFAs (mean age 53.0 ± 12.9 years, 78% women), 19 were manual and 56 robotic. Manual PFA experienced more 90-day complications (31% vs 10%, p = 0.0321) and a longer mean length of stay (30.9 ± 14.4 vs 20.6 ± 17.7 h, p = 0.03). No significant differences existed in age, BMI, gender, race, surgical time, 30-day complications, or revision rate. Manual PFA had no revisions, while 5% of robotic PFAs were revised for osteoarthritis progression, with a mean conversion time of 4.5 ± 2.7 years. Five-year cumulative percent revision (CPR) for all PFAs was 7.37%. Logistical regression showed manual PFA patients were more likely to experience 90-day complications (OR 3.84, p = 0.04). Conclusions: Manual PFA were prone to more 90-day complications and longer hospital stays compared to robotic PFA, which may minimize complications without affecting revision rates. Importantly, the PFA revision rate herein exceeded MARCQI-reported rates for unicompartmental and total knee arthroplasty.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.